Abstract
Invasive mucinous adenocarcinoma (IMA) is a rare type of lung cancer associated with poor prognosis since systemic chemo- and immunotherapies are generally ineffective and lack of actionable genomic alterations often preclude targeted therapy. While organ transplantation is excluded in patients with solid malignancies, we hypothesized that tumor extirpation through bilateral lung transplantation in a patient with lack of systemic metastasis could be a life-saving treatment in medically refractory IMA.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
